Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
2002
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Salvage endoscopic nasopharyngectomy and intensity‐modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma
2014
Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates
2003
A new applicator design for endocavitary brachytherapy of cancer in the nasopharynx
1997
Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
2013
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
2009 StandoutNobel
Head and neck squamous cell carcinoma
2020 Standout
Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual
2017 Standout
Fine mapping of the 11q22–23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma
2004
Nasopharyngeal carcinoma
2005 Standout
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time
2002
Expanding global access to radiotherapy
2015 Standout
The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma
2009
Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20‐year period (1980–99): An encouraging reduction in both incidence and mortality
2002
Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: Survival after local recurrence
1993
Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck
2007
Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography
1996
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma
2003
Thyroid cancer
2016 Standout
Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity
2001
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
High-dose, high-precision treatment options for boosting cancer of the nasopharynx
2002
Aggressive Cutaneous NK and NK-like T-Cell Lymphomas
1999
Cognitive Function of Patients With Nasopharyngeal Carcinoma With and Without Temporal Lobe Radionecrosis
2000
Distant Metastases from Nasopharyngeal Cancer
2001
Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study
2002
Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer
2001
Determination of subcutaneous tumor size in athymic (nude) mice
1989 Standout
Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications
2000
Hydroa-Like Cutaneous T-Cell Lymphoma: A Clinicopathologic and Molecular Genetic Study of 16 Pediatric Cases from Peru
2002
Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines
1990
Nasopharyngeal carcinoma: A medical oncology viewpoint. The Gustave Roussy experience
1990
Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma
2001
Presentation and epidemiology of nasopharyngeal carcinoma in Jordan
1999
Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
2016
Prognostic Significance of 18F-FDG PET Parameters and Plasma Epstein-Barr Virus DNA Load in Patients with Nasopharyngeal Carcinoma
2012
The 2004 World Health Organization classification of lung tumors
2005 Standout
Staging and follow-up of nasopharyngeal carcinoma: Magnetic resonance imaging versus computerized tomography
1995
Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma
2003
Individualized treatment in stage IVC nasopharyngeal carcinoma
2014
Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma
2012
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials
2006
Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma
2004
Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
2010
Head and neck cancer
2008 Standout
Extracranial carotid artery disease in nasopharyngeal carcinoma patients with post-irradiation ischemic stroke
2010
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum
2001
Locally Recurrent Nasopharyngeal Carcinoma: Treatment Results for Patients with Computed Tomography Assessment
1998
Detection of Stage I nasopharyngeal carcinoma by serologic screening and clinical examination
2011
Pharmacological actions and potential uses of Momordica charantia: a review
2004 Standout
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Nasopharyngeal carcinoma
2019 Standout
Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy
2011
Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials
2001
Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy
2002
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities
2013
Treatment of head and neck cancer: the role of chemotherapy
1996
Hypericin photoactivation triggers down-regulation of matrix metalloproteinase-9 expression in well-differentiated human nasopharyngeal cancer cells
2007
High Dose Rate Intracavitary Brachytherapy in the Treatment of Nasopharyngeal Carcinoma
1996
Where Is the Semantic System? A Critical Review and Meta-Analysis of 120 Functional Neuroimaging Studies
2009 Standout
The role of brachytherapy in early-stage nasopharyngeal carcinoma
1996
Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma
2012
Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma
2003
Conformity index: A review
2006 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma
2008
How Does Magnetic Resonance Imaging Influence Staging According to AJCC Staging System for Nasopharyngeal Carcinoma Compared With Computed Tomography?
2008
Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma
2007
The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma
1999
Global cancer statistics
2011 Standout
Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma
1993
Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma
2004
Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
1998
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Radiation Dose–Volume Effects in the Brain
2010
The new World Health Organization classification of lung tumours
2001
Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group
2004
Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma
2004
Nasopharyngeal carcinoma
2015 Standout
Relationships between nasopharyngeal carcinoma and radioactive elements in soils in China
2000
L'effet volume en radiothérapie première partie : effet volume et tumeur
2003
Malignant Gliomas in Adults
2008 Standout
Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience
2000
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
2014
Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy
2012
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Epstein–Barr virus: 40 years on
2004 Standout
Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control
1997
Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control
2004
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
The battle against nasopharyngeal cancer
2012
Epstein-barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepitheliomalike carcinoma of the urinary bladder
1995
Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma
2000
Head and Neck Cancer
1993 Standout
Classification of cytotoxic T-cell and natural killer cell lymphomas
2003
Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma: A significant factor in local control and distant metastasis
1996
A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5‐fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma
2004
Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
2004
Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era
2014
The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma
1997
MicroRNA signatures in human cancers
2006 Standout
Primary brain tumours in adults
2012 Standout
Radiation Dose–Volume Effects in the Heart
2010
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial
2006
Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy
2000
Radiotherapy for nasopharyngeal carcinoma: Shielding the pituitary may improve therapeutic ratio
1994
Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma
2000
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
2012
Another way to estimate outcome of advanced nasopharyngeal carcinoma—is concurrent chemoradiotherapy adequate?
2004
Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage
2002
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Nasopharyngeal Carcinoma: Review of How Imaging Affects Staging
1999
Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications
2000
Nasopharyngeal cancer WHO type II-III: monoinstitutional retrospective analysis with standard and accelerated hyperfractionated radiation therapy
2002
The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma
2001
Co‐expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
2000
Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma
2007
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma
2010
Blastic Natural Killer Cell Leukemia/Lymphoma: A Clinicopathologic Study
1997
Subcutaneous, Blastic Natural Killer (NK), NK/T-cell, and Other Cytotoxic Lymphomas of the Skin: A Morphologic, Immunophenotypic, and Molecular Study of 50 Patients
2004
Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years’ experience at Long Beach Memorial
2000
Treatment outcome after radiotherapy alone for patients with Stage I–II nasopharyngeal carcinoma
2003
Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis
2015
Head and Neck Cancer
2001 Standout
The Association of Epstein-Barr Virus (Ebv) with T Cell Lymphoproliferations and hodgkin's Disease: Two New Developments in the Ebv Field
1993
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
2000 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Epstein–Barr Virus Infection
2000 Standout
Radiation‐related cranial nerve palsy in patients with nasopharyngeal carcinoma
2002
Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.
1998
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Proposal for the 8th edition of the AJCC /UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy
2015
Surgical salvage for recurrent retropharyngeal lymph node metastasis in nasopharyngeal carcinoma
2013
Management of glioblastoma: State of the art and future directions
2020 Standout
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results
2018
Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.
2000
Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial
2002
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
1997 Standout
Detection of Epstein-Barr Virus DNA in the Peripheral-Blood Cells of Patients With Nasopharyngeal Carcinoma: Relationship to Distant Metastasis and Survival
2001
Concurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial Study
2004
Herpes simplex encephalitis: long term magnetic resonance imaging and neuropsychological profile.
1994
Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma
2001
Natural Killer/Natural Killer-Like T-Cell Lymphoma, CD56+, Presenting in the Skin: An Increasingly Recognized Entity With an Aggressive Course
2001
Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival
2003
Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: An indication for more aggressive treatment
1996
Evidence on effectiveness of intensity‐modulated radiotherapy versus 2‐dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta‐analysis and a systematic review of the literature
2014
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Long-Term Disease-Free Survivors in Metastatic Undifferentiated Carcinoma of Nasopharyngeal Type
2000
p16 gene alterations in nasopharyngeal carcinoma.
1995
Nonnasal Lymphoma Expressing the Natural Killer Cell Marker CD56: A Clinicopathologic Study of 49 Cases of an Uncommon Aggressive Neoplasm
1997
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
2009
A comparison of different staging systems predictability of patient outcome
1997
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
2008
Results of a Prospective Randomized Trial Comparing Neoadjuvant Chemotherapy Plus Radiotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
2001
Epstein-Barr Virus Infection, Salted Fish and Nasopharyngeal Carcinoma: A case-control study in Southern
1994
Central Nervous System Injury by Therapeutic Irradiation
1991
Progress of Memory Function After Radiation Therapy in Patients With Nasopharyngeal Carcinoma
2003
Cancer Susceptibility in Nasopharyngeal Carcinoma Families—A Population-Based Cohort Study
2005
Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer.
2000
A Literature Review of Late Complications of Radiation Therapy for Head and Neck Cancers: Incidence and Dose Response
2013
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma
1996
Guidelines for the management of thyroid cancer
2014 Standout
Global cancer statistics, 2012
2015 Standout
Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis.
1997
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
2001
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma.
2002
An in vivo model for squamous cell carcinoma of the head and neck
1985
Thyroid carcinoma
2003 Standout
Accelerated Concomitant Boost Radiotherapy and Chemotherapy for Advanced Nasopharyngeal Carcinoma
2001
Long‐term outcomes after reirradiation in nasopharyngeal carcinoma with intensity‐modulated radiotherapy: A meta‐analysis
2017
Works of Y.F. Poon being referenced
Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure
1992
A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma
1994
Staging of nasopharyngeal carcinoma: From Ho's to the new UICC system
1999
In situ localization of epstein-barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas
1994
Primary lymphoepithelioma-like carcinoma of the lung. A clinicopathologic study of 11 cases
1995
Detection of Epstein-Barr Viral RNA in Malignant Lymphomas of the Upper Aerodigestive Tract
1994
Staging of nasopharyngeal carcinoma: Evaluation of N-staging by Ho and UICC/AJCC systems
1996
Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma
2000
Reirradiation for recurrent nasopharyngeal carcinoma: Factors affecting the therapeutic ratio and ways for improvement
1997
Remarkable Application of Serum EBV EBER‐1 in Monitoring Response of Nasopharyngeal Cancer Patients to Salvage Chemotherapy
2001
Nasopharyngeal carcinoma in young patients
1990
Magnetic resonance imaging in the clinical diagnosis of late temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma
1990
Recurrent nasopharyngeal carcinoma: the puzzles of long latency
1999
Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma
1995
Treatment of stage I nasopharyngeal carcinoma: Analysis of the patterns of relapse and the results of withholding elective neck irradiation
1989
Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma
1988
Effect of Time, Dose, and Fractionation on Temporal Lobe Necrosis Following Radiotherapy for Nasopharyngeal Carcinoma
1998
Retrospective analysis of nasopharyngeal carcinoma treated during 1976–1985: late complications following megavoltage irradiation
1992
Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx
1980
Immunophenotypic analysis of non-hodgkin's lymphomas in Chinese. A study of 75 cases in Hong Kong
1986
Specific association of Epstein-Barr virus with lymphoepithelial carcinoma among tumors and tumorlike lesions of the salivary gland.
1994
Nasopharyngeal carcinoma: local control by megavoltage irradiation
1993